Loss of Bile Salt Export Pump (Bsep/Abcb11) Ameliorates Toxin-induced Hepatic Fibrosis via Suppression of Hepatocellular Jun Amino-terminal Kinase Signaling and Hepatic Stellate Cell Activation
Claudia Fuchs(Medical University of Vienna), Michael Trauner(Medical University of Graz), Emmanuel D. Dixon(Medical University of Vienna), Hubert Scharnagl(Medical University of Graz), Tatjana Stojaković, Thomas Reiberger(Harvard University), Veronika Mlitz(Medical University of Vienna), Thierry Claudel(Medical University of Vienna), Philipp Königshofer(Medical University of Vienna)
Cited by 1
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239